既往剖宫产对妊娠滋养细胞肿瘤风险的影响
该回顾性研究纳入1995至2016年182例妊娠滋养细胞疾病患者,比较既往剖宫产组与非剖宫产组。剖宫产组发生妊娠滋养细胞肿瘤、侵袭性葡萄胎、子宫切除及化疗的比例均更高;多因素分析显示既往剖宫产是妊娠滋养细胞肿瘤的独立危险因素。
要点
- 既往剖宫产是妊娠滋养细胞肿瘤的独立危险因素(HR 5.1)。
- 剖宫产组侵袭性葡萄胎和子宫切除比例显著更高。
- 有剖宫产史者可考虑更积极的治疗如多药化疗或子宫切除。
核心结论
- 既往剖宫产是妊娠滋养细胞肿瘤和侵袭性葡萄胎发生的强烈危险因素。
- 对于有剖宫产史的妊娠滋养细胞疾病患者,可考虑更积极的治疗如多药化疗或子宫切除。
研究设计与样本
- 回顾性研究,纳入1995至2016年间治疗的182例妊娠滋养细胞疾病患者。
- 比较既往剖宫产组与非剖宫产组的临床特征及结局。
- 采用单因素和多因素Cox比例风险模型估计风险比(HR)和95%置信区间(CI)。
主要发现
- 剖宫产组年龄(37.0 vs 32.8,p=0.004)、孕次(3.1 vs 2.0,p<0.001)和产次(1.6 vs 0.9,p<0.001)均高于非剖宫产组。
- 剖宫产组妊娠滋养细胞肿瘤(43.5 vs 26.5%,p<0.001)、侵袭性葡萄胎(21.7 vs 3.7%,p<0.001)、子宫切除(28.3 vs 6.6%,p<0.001)和化疗(45.7 vs 28.7%,p=0.03)比例更高。
- 多因素分析中,妊娠滋养细胞肿瘤的独立危险因素包括既往剖宫产(HR 5.1,95% CI 2.1-12.7)、流产史(HR 6.3,95% CI 2.5-15.6)和治疗前β-hCG(HR 1.3,95% CI 1.1-1.6)。
临床怎么用
- 对妊娠滋养细胞疾病患者应详细询问剖宫产史以评估妊娠滋养细胞肿瘤风险。
- 有剖宫产史者发生妊娠滋养细胞肿瘤风险较高,可考虑更积极的治疗策略如多药化疗或子宫切除。
局限性
- 本研究为单中心回顾性研究,样本量有限(182例),可能存在选择偏倚。
- 剖宫产组年龄、孕产次均较高,可能影响结局比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the relationship between previous cesarean section (C/S) and risk for post-molar gestational trophoblastic neoplasia (GTN). METHODS: Data from patients who were treated for hydatidiform moles between 1995 and 2016 were retrospectively reviewed. Patient age, gravidity, parity, abortion history, gestational age, pretreatment beta-human chorionic gonadotropin (HCG), previous molar pregnancy, clinical symptoms, enlarged uterus, theca lutein cyst, type of GTN, World Health Organization risk score, chemotherapy, and mode of delivery were recorded. Hazard ratios (HR) and 95% confidence intervals (CI) for variables associated with the occurrence of post-molar GTN and invasive mole were estimated by univariate and multivariate Cox proportional hazards models. RESULTS: From 1995 to 2016, 182 patients were diagnosed with molar pregnancy and underwent treatment. Patients with previous C/S (C/S group) had higher age (37.0 vs 32.8. p = 0.004), gravidity (3.1 vs 2.0, p < 0.001), and parity (1.6 vs 0.9, p < 0.001) than patients without previous C/S (non-C/S group). Post-molar GTN (43.5 vs 26.5%, p < 0.001), invasive mole (21.7 vs 3.7%, p < 0.001), hysterectomy (28.3 vs 6.6%, p < 0.001), and chemotherapy (45.7 vs 28.7%, p = 0.03) were more frequent in the C/S group. In multivariate analysis, independent risk factors for post-molar GTN were previous C/S (HR 5.1, 95% CI 2.1-12.7), abortion history (HR 6.3, 95% CI 2.5-15.6), and pretreatment β-hCG (HR 1.3, 95% CI 1.1-1.6). CONCLUSIONS: In this study, C/S was a strong risk factor for occurrence of post-molar GTN and invasive mole. Aggressive treatment, such as multi-agent chemotherapy or hysterectomy, can be considered for hydatidiform moles in patients with a C/S history.
引用
- Cho HW, Ouh YT, Min KJ, et al. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN). Gynecol Oncol. 2020. PMID: 31954533. doi:10.1016/j.ygyno.2019.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。